Oncology & Targeted Therapies

Oncology & Targeted Therapies

The Oncology & Targeted Therapies track focuses on the latest advancements in cancer research, diagnosis, and personalized treatment strategies. This track highlights breakthroughs in molecular oncology, tumor biology, immunotherapy, and precision-based targeted treatments designed to attack specific genetic and cellular abnormalities. Sessions will explore the development of small molecule inhibitors, monoclonal antibodies, antibody–drug conjugates, and CAR-T cell therapies, emphasizing improved efficacy and reduced systemic toxicity compared to conventional chemotherapy. Attention will also be given to biomarker-driven treatment selection and resistance mechanisms that influence therapeutic outcomes. In addition, the track addresses innovative clinical trial designs, combination therapies, and translational research approaches that accelerate the development of next-generation cancer treatments.

  • Oncology Research & AI-Enabled Therapeutics
  • Biomarker-Driven Trial Innovation

Related Sessions



Quick Links

Contact Us

Scitechseries Publishing Limited
71-75, Shelton, Covent Garden
London, WC2H 9JQ

Email: clinicaltrails@scitechconference.com
Phone: +44 2045874848
WhatsApp: +44 7429481517

Sponsor/Exhibition:
Email: sponsorship@scitechseries.org

© 2026 All Rights Reserved by Scitechseries
Terms and Conditions | Privacy Policy